That's important, because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we need to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (jeff brown biotech pick). And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're designed to do. This was a development practically no one discovered. However it's going to have profound implications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be lots of financial investment chances in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (longtime readers). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back perhaps considerably prior to going greater - artificial intelligence. I have actually been covering bitcoin for a long period of time now. Among the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. However that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown predictions 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous great personal companies on the brink of hitting the public markets And I've been dealing with a brand-new way for you to invest even before these business go public.
This opportunity has actually been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your spot free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our normal beat (jeff brown 2020 predictions). And when it concerns tech investing, we leave it to the professionals. The good news is, we have several such professionals in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we understand (jeff brown biotech picks). In reality, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid development and creating incredible opportunities for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. angel investor. However despite what lots of readers might think, this is a pattern that's simply getting going. Although the COVID-19 pandemic disrupted supply chains last year, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (second wave). Losing 2 months of manufacturing and sales truly impacts the number of 5G devices are offered in the fiscal year. When you think about all of that, selling 250 million systems is exceptional. More notably, the hold-ups triggered by the pandemic developed a lots of suppressed need. And that need is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - self-driving cars. And that's not my only 5G forecast When I've spoken about 5G in the past, I have actually explained its three various stages.
In Stage 2, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Stage Three, 5G services begin to be offered (brownstone research stock). That's when we start to see applications operating on 5G networks. Think about things like huge multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage Three by this summer season. This starts something of a virtuous cycle: A lot of individuals don't actually care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open up a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next essential innovation I predict in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a comparable concept but with our hereditary code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well understood. And during that time, there were really only three companies operating in this space. But things are altering. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with illness and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering unbelievable returns. This entire industry is effectively a greenfield opportunity.
There's space for numerous companies to exist in this area. jeff brown biotech stock. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or three more genetic editing business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things happening at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software can accurately anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential since the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're developed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced utilizing this technology. This was one of those breakthroughs that almost no one observed. However it's going to have profound implications for treating illness. And, naturally, there will be lots of investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly significantly before going higher. I've been covering bitcoin for a long time now. Among the very first research study reports I ever published was on bitcoin - jeff brown biotech picks. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my suggestion. However at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. jeff brown investment prediction. Mass, Mutual is a 150-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the information is up to date as of February 2021, but we could not individually verify this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like capability to pick winning technology stocks. He spent more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an excellent viewpoint on the market. He's constantly on the hunt for brand-new chances, and he shares a number of his finest picks in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully forecasted a few of the greatest economic events of the past twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal every time, but Jeff Brown's precise predictions have earned him legions of dedicated fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research study provides several research study services with a variety of specializations - jeff brown biotech pick.
The company is also associated with Bonner & Partners, another well-respected research publisher - biotech stock. On its website, Brownstone states its mission is to provide retail financiers with professional-grade research: "For too long, the very best financial investment research study has not been available to specific financiers. It has actually been usually scheduled for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown 2020 predictions. The mission of Brownstone Research study is to make that kind of proprietary research study available to any financiers seeking to get an edge in the marketplaces. The goal is basic to deliver unique and profitable investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise serves as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you know even a little bit about the marketplace, you know that he has a credibility as a King Midas of sorts. angel investor. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown believes S.A.V. last year. might be "the greatest pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying 2 innovative technologies: expert system and electric cars and trucks. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing brief of the automotive market's Holy Grail. As you know, electric lorries and self-driving cars and truck stocks have actually been substantial this year, however the Wall Street machine has actually been big on hype without much concrete outcome. Despite an extreme boost in competition over the past few years, Brown still thinks Musk has the best opportunity of putting everything together.
tech could be the magic string that ties everything together. S.A.V. means Shared Autonomous Car, and it could be the future of transportation. Generally, this innovation would allow you to lease your car as a self-governing, self-driving taxi when you're not utilizing it. You just get out of the cars and truck and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a substantial piece of the profits. It sounds ridiculous, however it might be closed than you think.